Merck & Co. is enjoying a spurt of new drug launches, partly due to its $41 billion November acquisition of New Jersey neighbor Schering-Plough Corp. Some have been on the market in the United States for a while, including blockbuster diabetes medicine Januvia, and are now being launched in other countries.
DRUG NAME
CONDITION/USE
WHERE IT'S LAUNCHING
Asmanex
Asthma
Bridion
Reversal of anesthesia
30 countries outside the U.S.
Elonva
Fertility treatment
Januvia
Type 2 diabetes
Japan
Depression
Japan
Saflutan
Glaucoma
European Union
Saphris
Schizophrenia/bipolar disorder
United States
Immune disorders
5 countries
Tredaptive
Hardening of the arteries
27 countries outside the U.S.
___
Data as of March 1. Source: Merck & Co.
Copyright 2010 AP Features
